Physician profile
Iman Ghaderi
NPI 1790069847
$4,435.97
in general payments reported to CMS, 2019-2025
10 companies · $963 in 2025
The $963 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,483 · 2020: $46.46 · 2021: $73.95 · 2022: $323 · 2024: $546 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770 · Travel and Lodging: $497 · Gift: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.98 |
| Travel and Lodging | $496.71 |
| Gift | $243.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,840.84 | 2019-2025 | |
| Endogastric Solutions, INC | $777.35 | 2019 | |
| Medtronic, INC. | $320.74 | 2021-2024 | Signia, Ligasure |
| Baxter Healthcare | $142.76 | 2019-2025 | Floseal, Tisseel |
| Davol INC. | $141.68 | 2022 | |
| Becton, Dickinson and Company | $107.94 | 2022 | |
| W. L. Gore & Associates, INC. | $46.46 | 2020 | |
| Covidien LP | $43.73 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.47 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iman Ghaderi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.